Howell Lydia Pleotis, Gurusinghe Sunitha, Tabnak Farzaneh, Sciortino Stan
Department of Pathology and Laboratory Medicine, University of California, Davis School of Medicine, 4400 V Street, Sacramento, CA 95817, USA.
Cancer Detect Prev. 2009;32(5-6):372-9. doi: 10.1016/j.cdp.2009.02.001. Epub 2009 Mar 4.
This study focuses on age, race/ethnicity and regular cervical cancer screening of medically underserved Latina and non-Latina women enrolled in California's Cancer Detection Programs: Every Woman Counts (CDP: EWC).
Data from a cohort of women were evaluated for regularity of screening and ethnicity utilizing multi-category logistic regression models to investigate Pap test and biopsy results.
There was no statistically significant difference among medically underserved Latina or non-Latina women in Pap test result and stage of cervical cancer after controlling for age and screening regularity. Rarely/never Pap-tested women were more likely to have 'SIL/ASC' (odds ratio=1.19; 95% confidence interval=1.08, 1.31) compared to women who were screened regularly. Medically underserved 25-39-year-old women were also more likely to be identified with 'SIL/ASC' (odds ratio=1.64; 95% confidence interval=1.50, 1.79) than women 50 and over. Younger were more likely to have low-grade 'HPV/Condylomata, Atypia/CINI/LSIL' (odds ratio=2.48; 95% confidence interval=1.66, 3.72) and high-grade 'CIN II/III/HSIL/CI/Other Cancers' (odds ratio=1.53; 95% confidence interval=1.08, 2.16) than women age 40 and above, similar to rarely/never Pap-tested women.
Women were more likely to be identified with high-grade precancerous cervical lesions and cancer process when they did not have regular screening, Ethnic differences in screening outcomes seem to be minimized by participation in a program that provides consistent screening resources to the medically underserved women who enroll. These findings support prevention strategies that expand screening to all medically underserved younger women or that provide HPV vaccination at an early age.
本研究聚焦于参加加利福尼亚癌症检测项目“每个女性都重要”(CDP:EWC)的医疗服务不足的拉丁裔和非拉丁裔女性的年龄、种族/族裔以及宫颈癌定期筛查情况。
利用多类别逻辑回归模型评估一组女性的数据,以研究巴氏试验和活检结果的筛查规律性和种族情况。
在控制年龄和筛查规律性后,医疗服务不足的拉丁裔或非拉丁裔女性在巴氏试验结果和宫颈癌分期方面没有统计学上的显著差异。与定期接受筛查的女性相比,很少/从未接受巴氏试验的女性更有可能出现“鳞状上皮内病变/非典型鳞状细胞”(优势比=1.19;95%置信区间=1.08,1.31)。25至39岁医疗服务不足的女性也比50岁及以上的女性更有可能被诊断为“鳞状上皮内病变/非典型鳞状细胞”(优势比=1.64;95%置信区间=1.50,1.79)。与40岁及以上的女性相比,年轻女性更有可能出现低级别“人乳头瘤病毒/湿疣、非典型性/CINI/LSIL”(优势比=2.48;95%置信区间=1.66,3.72)和高级别“CIN II/III/HSIL/CI/其他癌症”(优势比=1.53;95%置信区间=1.08,2.16),这与很少/从未接受巴氏试验的女性情况类似。
未进行定期筛查的女性更有可能被诊断为高级别宫颈癌前病变和癌症进程。通过参与一个为登记的医疗服务不足女性提供持续筛查资源的项目,筛查结果中的种族差异似乎被最小化。这些发现支持将筛查扩大到所有医疗服务不足的年轻女性或在早期提供人乳头瘤病毒疫苗接种的预防策略。